(Q36055051)

11 August 2017

Phenotypic polymorphism and gender-related differences of CYP1A2 activity in a Chinese population (English)

1 reference

11 August 2017

D S Ou-Yang

1

1 reference

11 August 2017

S L Huang

2

1 reference

11 August 2017

W Wang

3

1 reference

11 August 2017

H G Xie

4

1 reference

11 August 2017

Z H Xu

5

1 reference

11 August 2017

Y Shu

6

1 reference

11 August 2017

H H Zhou

7

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 February 2000

1 reference

British Journal of Clinical Pharmacology

11 August 2017

1 reference

11 August 2017

49

1 reference

11 August 2017

2

1 reference

11 August 2017

145-151

1 reference

Detection of a novel cytochrome P-450 1A2 polymorphism (F21L) in Chinese

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014904

Characterization of two nuclear proteins that interact with cytochrome P-450 1A2 mRNA. Regulation of RNA binding and possible role in the expression of the Cyp1a2 gene

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014904

P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.

2 October 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014904

2 October 2017

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2000.00128.X

CYP1A2 activity, gender and smoking, as variables influencing the toxicity of caffeine

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014904

Role of cytochrome P4501A2 in chemical carcinogenesis: implications for human variability in expression and enzyme activity.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014904

The use of caffeine for enzyme assays: a critical appraisal

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014904

The human CYP1A2 gene and induction by 3-methylcholanthrene. A region of DNA that supports AH-receptor binding and promoter-specific induction

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014904

Caffeine, estradiol, and progesterone interact with human CYP1A1 and CYP1A2. Evidence from cDNA-directed expression in Saccharomyces cerevisiae

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014904

Biochemical individuality and its implications for drug and carcinogen metabolism: recent insights from acetyltransferase and cytochrome P4501A2 phenotyping and genotyping in humans

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014904

Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014904

CYP1A2 activity as a risk factor for bladder cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014904

Caffeine as a metabolic probe: a comparison of the metabolic ratios used to assess CYP1A2 activity

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014904

A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014904

Testing for bimodality in frequency distributions of data suggesting polymorphisms of drug metabolism--hypothesis testing

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014904

Testing for bimodality in frequency distributions of data suggesting polymorphisms of drug metabolism--histograms and probit plots

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014904

Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014904

Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014904

Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014904

Simple and reliable CYP1A2 phenotyping by the paraxanthine/caffeine ratio in plasma and in saliva.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014904

Evaluation of two assumptions: single straight line, and single normal distribution.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014904

Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014904

Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014904

Evaluation of caffeine as a test drug for CYP1A2, NAT2 and CYP2E1 phenotyping in man by in vivo versus in vitro correlations.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014904

Caffeine urinary metabolite ratios as markers of enzyme activity: a theoretical assessment.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014904

Lifestyle and nutritional correlates of cytochrome CYP1A2 activity: inverse associations with plasma lutein and alpha-tocopherol.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014904

Validation of urine caffeine metabolite ratios with use of stable isotope-labeled caffeine clearance

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014904

Caffeine as a probe for CYP1A2 activity: potential influence of renal factors on urinary phenotypic trait measurements

23 September 2018

1 reference

12 December 2020

The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferases in man using sparteine, caffeine, and paracetamol as probes

1 reference

12 December 2020

A population and family study of CYP1A2 using caffeine urinary metabolites

1 reference

12 December 2020

Regulation of the constitutive expression of the human CYP1A2 gene: cis elements and their interactions with proteins

1 reference

12 December 2020

Limitations of probit plots in pharmacogenetics: requirement of genetic analyses to test hypotheses based on graphical methods

1 reference

12 December 2020

Influence of ethinylestradiol-containing combination oral contraceptives with gestodene or levonorgestrel on caffeine elimination

1 reference

12 December 2020

Caffeine induces cytochrome P4501A2: induction of CYP1A2 by tea in rats

1 reference

12 December 2020

Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine

1 reference

12 December 2020

Identification of positive and negative regulatory elements of the human cytochrome P4501A2 (CYP1A2) gene

1 reference

12 December 2020

Role of human hepatic cytochrome P450 1A2 and 3A4 in the metabolic activation of estrone

1 reference

12 December 2020

Effect of quinolones on caffeine disposition

1 reference

12 December 2020

Genetic polymorphism in the 5'-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans

1 reference

12 December 2020

Use of caffeine as a probe for rapid determination of cytochrome P-450 CYP1A2 activity in humans

1 reference

12 December 2020

Detailed modelling of caffeine metabolism and examination of the CYP1A2 gene: lack of a polymorphism in CYP1A2 in Caucasians

1 reference

12 December 2020

Caffeine as a metabolic probe: exploration of the enzyme-inducing effect of cigarette smoking

1 reference

12 December 2020

Quinolone inhibition of cytochrome P-450-dependent caffeine metabolism in human liver microsomes

1 reference

12 December 2020

Evidence for the involvement of several cytochromes P-450 in the first steps of caffeine metabolism by human liver microsomes

1 reference

12 December 2020

Foreign compound metabolism capacity in man measured from metabolites of dietary caffeine

1 reference

12 December 2020

Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities

1 reference

12 December 2020

Menstrual cycle effects on caffeine elimination in the human female

1 reference

12 December 2020

Acetylation phenotype and cytochrome P450IA2 phenotype are unlikely to be associated with peripheral arterial disease.

1 reference

12 December 2020

Regiospecific expression of cytochrome P-450s and microsomal epoxide hydrolase in human brain tissue

1 reference

12 December 2020

Phenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites: absence of mutation prescribing the phenotype in the CYP1A2 gene

1 reference

12 December 2020

10.1046/J.1365-2125.2000.00128.X

Identifiers

DOI

1 reference

11 August 2017

1 reference

11 August 2017

1 reference